Complete Wegovy vs Mounjaro Dosage and Pricing Guide
Wegovy vs Mounjaro Dosage: Understanding the Key Differences
The primary distinction in Wegovy vs Mounjaro dosage lies in their escalation schedules and underlying mechanisms. Wegovy follows a 5-step progression over 16 weeks (0.25mg, 0.5mg, 1mg, 1.7mg, then 2.4mg maintenance), whilst Mounjaro uses a 4-step escalation (2.5mg, 5mg, 10mg, then 15mg maximum). This difference reflects their distinct pharmacological profiles - Wegovy's semaglutide targets GLP-1 receptors exclusively, whereas Mounjaro's tirzepatide activates both GIP and GLP-1 pathways simultaneously. Understanding these dosing patterns helps prescribers determine which treatment aligns with your tolerance profile and weight management goals.
When comparing Wegovy vs Mounjaro dosage schedules, timing becomes crucial for treatment success. Wegovy requires a more gradual 16-week escalation to minimise gastrointestinal side effects, particularly during the initial 0.25mg phase. Mounjaro's escalation occurs over 12 weeks, with each dose maintained for 4 weeks before progression. Both treatments require this careful dose escalation - jumping ahead or skipping doses significantly increases the risk of nausea, vomiting, and treatment discontinuation. Your prescriber will monitor your response at each stage to ensure optimal tolerability.
Wegovy vs Mounjaro Dosage Pricing with Exclusive Discount Codes
Our transparent Wegovy vs Mounjaro dosage pricing removes the guesswork from treatment costs. Wegovy pricing starts at £79.99 for the 0.25mg starter dose, progressing to £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), and £209.99 for the 2.4mg maintenance dose. New customers apply discount code FIRST40 at checkout to access these prices, whilst returning customers use DOSE25. Our Getting Started bundles provide convenience for dose transitions - the Intro Duo (0.25mg & 0.5mg) costs £169.99, whilst the Progress Duo (0.5mg & 1mg) is priced at £189.99.
Comparing Wegovy vs Mounjaro dosage costs reveals different pricing structures reflecting their distinct pharmaceutical profiles. Mounjaro pricing follows its own escalation pattern, with transparent costs displayed during our clinical assessment process. Both treatments qualify for our discount codes - FIRST40 for new customers and DOSE25 for returning customers, applied automatically at checkout. Our bundle pricing provides Reliable Supply continuity, eliminating the stress of reordering during critical dose transition periods. The Ultimate Stability Trio (three 2.4mg Wegovy pens) ensures three months of maintenance supply for £649.99, providing peace of mind for long-term treatment.
Clinical Evidence Comparing Wegovy vs Mounjaro Dosage Effectiveness
Clinical trials demonstrate that both treatments, when used alongside a reduced-calorie diet and increased physical activity, may support significant weight management outcomes. The STEP trials for Wegovy showed that participants achieved an average of approximately clinically studied weight loss at 68 weeks when using the full 2.4mg maintenance dose (Wilding et al., NEJM, 2021). These results were observed in conjunction with lifestyle modifications and medical supervision throughout the dosing escalation period.
Mounjaro's SURMOUNT trials indicated that the highest dose (15mg) supported substantial weight management outcomes in clinical settings. However, comparing Wegovy vs Mounjaro dosage effectiveness directly requires careful consideration, as trials used different populations, endpoints, and methodologies. Both treatments demonstrated their effectiveness when patients completed the full dose escalation protocol without skipping steps, highlighting the importance of adherence to prescribed dosing schedules under medical supervision.
How Wegovy Works: GLP-1 Mechanism Behind the Dosage Schedule
Wegovy's semaglutide acts as a GLP-1 receptor agonist, mimicking the natural incretin hormone that regulates appetite and food intake. The medication works by binding to GLP-1 receptors in the brain's appetite control centres, promoting feelings of satiety after smaller meals and potentially reducing food cravings between meals. This mechanism explains why the Wegovy vs Mounjaro dosage escalation is essential - starting at 0.25mg allows your body to gradually adapt to these appetite-regulating effects. The slow progression to 2.4mg maintenance dose optimises therapeutic benefits whilst minimising gastrointestinal side effects. Additionally, Wegovy may slow gastric emptying, contributing to prolonged feelings of fullness after eating.
Ordering Process: Accessing Wegovy vs Mounjaro Dosage Options
Obtaining either treatment through EverydayMeds begins with our comprehensive 3-minute online clinical assessment, designed to evaluate your suitability for each dosing protocol. Our qualified prescribers review your medical history, current medications, and weight management goals to determine whether Wegovy vs Mounjaro dosage schedules align with your individual needs. Standard prescriber review takes 3 working days, with express 24-hour review available for urgent requirements. Once approved, your chosen treatment ships via next-day delivery using cold-chain, temperature-controlled packaging to maintain medication integrity. Our GPhC-registered pharmacy (#9012878) ensures all prescription-only medicines meet strict UK quality standards throughout the dispensing and delivery process.
Storage Considerations: Wegovy vs Mounjaro Dosage Practicality
Storage requirements present a key practical difference when comparing Wegovy vs Mounjaro dosage options for daily life. Wegovy offers superior travel flexibility, remaining stable for up to 6 weeks at room temperature (below 30°C) once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both treatments require refrigeration at 2-8°C before first use and utilise pre-filled injection pens for convenient once-weekly administration. Wegovy's FlexTouch pen design provides dose accuracy throughout the escalation schedule, from the initial 0.25mg dose through to 2.4mg maintenance. This extended room temperature stability makes Wegovy particularly suitable for frequent travellers or those with variable schedules during their dose escalation journey.
Wegovy vs Mounjaro Dosage: Personalised Treatment Selection Strategy
Choosing between Wegovy vs Mounjaro dosage protocols requires careful consideration of your individual tolerance profile and treatment history. Patients with previous GLP-1 experience may tolerate Wegovy's escalation more readily, whilst GLP-1 naive patients often benefit from the gradual 0.25mg starting dose. Your prescriber will evaluate factors including gastrointestinal sensitivity, concurrent medications, and weight management timeline when recommending the optimal dosing approach. Both treatments require commitment to the full escalation schedule - discontinuing during dose transitions significantly reduces long-term success rates.
The dual mechanism of Mounjaro versus Wegovy's single GLP-1 pathway creates different dosing considerations for various patient populations. Some individuals respond optimally to Wegovy's targeted GLP-1 approach, whilst others may benefit from Mounjaro's broader hormonal effects. Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which dosing protocol aligns with your medical profile. Neither treatment should be considered superior without individual clinical context - the best choice depends on your specific circumstances, tolerance, and treatment goals.
Secure Your Wegovy vs Mounjaro Dosage with Discount Codes
Ready to begin your weight management journey with transparent pricing and professional support? Apply discount code FIRST40 (new customers) or DOSE25 (returning customers) at checkout to access our competitive rates starting from £79.99 for Wegovy or equivalent Mounjaro pricing. Our clinical team stands ready to guide you through the Wegovy vs Mounjaro dosage comparison during your assessment, ensuring you receive the most suitable prescription-only medicine for your needs. Visit https://everydaymeds.co.uk/collections/wegovy to complete your clinical assessment and discover which treatment protocol offers the best foundation for your weight management success. Both treatments are available through our GPhC-registered pharmacy (#9012878), backed by next-day delivery and ongoing clinical support throughout your dosing journey. Take the first step towards informed treatment selection with EverydayMeds today.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
